These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36401646)

  • 41. A PK-PD model of ketamine-induced high-frequency oscillations.
    Flores FJ; Ching S; Hartnack K; Fath AB; Purdon PL; Wilson MA; Brown EN
    J Neural Eng; 2015 Oct; 12(5):056006. PubMed ID: 26268223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects.
    van Berckel BN; Lipsch C; Timp S; Gispen-de Wied C; Wynne H; van Ree JM; Kahn RS
    Neuropsychopharmacology; 1997 May; 16(5):317-24. PubMed ID: 9109102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens.
    Goda SA; Piasecka J; Olszewski M; Kasicki S; Hunt MJ
    Psychopharmacology (Berl); 2013 Jul; 228(2):271-82. PubMed ID: 23525524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis.
    Klodzińska A; Chojnacka-Wójcik E
    Psychopharmacology (Berl); 2000 Oct; 152(2):224-8. PubMed ID: 11057527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-cycloserine enhances rapid tolerance to ethanol motor incoordination.
    Khanna JM; Morato GS; Chau A; Shah G
    Pharmacol Biochem Behav; 1995 Nov; 52(3):609-14. PubMed ID: 8545482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of high-frequency oscillations associated with NMDA receptor hypofunction in the rodent nucleus accumbens by lamotrigine.
    Hunt MJ; Garcia R; Large CH; Kasicki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1312-9. PubMed ID: 18514376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.
    Horacek J; Brunovsky M; Novak T; Tislerova B; Palenicek T; Bubenikova-Valesova V; Spaniel F; Koprivova J; Mohr P; Balikova M; Hoschl C
    Psychol Med; 2010 Sep; 40(9):1443-51. PubMed ID: 19995475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.
    Bowman C; Richter U; Jones CR; Agerskov C; Herrik KF
    Front Psychiatry; 2022; 13():737295. PubMed ID: 35153870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of NMDA receptor modulation on hippocampal type 2 theta activity in rats.
    Pitkänen M; Sirviö J; Ylinen A; Koivisto E; Riekkinen P
    Gen Pharmacol; 1995 Sep; 26(5):1065-70. PubMed ID: 7557252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Therapeutic Role of d-Cycloserine in Schizophrenia.
    Goff D
    Adv Pharmacol; 2016; 76():39-66. PubMed ID: 27288073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals.
    Price KL; Baker NL; McRae-Clark AL; Saladin ME; Desantis SM; Santa Ana EJ; Brady KT
    Psychopharmacology (Berl); 2013 Apr; 226(4):739-46. PubMed ID: 22234379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
    Nugent AC; Diazgranados N; Carlson PJ; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Drevets WC; Zarate CA
    Bipolar Disord; 2014 Mar; 16(2):119-28. PubMed ID: 24103187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
    Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
    Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NMDA receptor antagonist-enhanced high frequency oscillations: are they generated broadly or regionally specific?
    Olszewski M; Dolowa W; Matulewicz P; Kasicki S; Hunt MJ
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1795-805. PubMed ID: 23466347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans.
    Kalisch R; Holt B; Petrovic P; De Martino B; Klöppel S; Büchel C; Dolan RJ
    Cereb Cortex; 2009 Jan; 19(1):187-96. PubMed ID: 18477687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
    Carlsson ML; Engberg G; Carlsson A
    J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.
    Grent-'t-Jong T; Rivolta D; Gross J; Gajwani R; Lawrie SM; Schwannauer M; Heidegger T; Wibral M; Singer W; Sauer A; Scheller B; Uhlhaas PJ
    Brain; 2018 Aug; 141(8):2511-2526. PubMed ID: 30020423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers.
    Schulte H; Graven-Nielsen T; Sollevi A; Jansson Y; Arendt-Nielsen L; Segerdahl M
    Acta Anaesthesiol Scand; 2003 Sep; 47(8):1020-30. PubMed ID: 12904196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.